64x Bio

Gene therapy offers patients with rare diseases access to life saving treatments. The lack of highly productive cell lines, however, has been a persistent bottleneck in manufacturing gene therapies, which is an exceedingly complex and costly process. Founded by experts at Harvard University and the Wyss Institute for Biologically Inspired Engineering, 64x Bio is engineering cell lines to address these critical manufacturing challenges.